8WL-20300-35985
4 vaccinations
4 coded responses
37 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 559 / MN
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-22
Dose 2 — Pfizer-BioNTech
-
2021-02-22
Survey response — day 0, dose 2MedDRA: Malaise — Feeling: Fair · Headache, Fatigue or tirednessFree text: A bit out of sorts, no pain. Safe!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Apathy — Feeling: Good · Fatigue or tirednessFree text: Lack of motivation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-05-24
- 2021-08-24
-
2021-10-07
Dose 3 — Pfizer-BioNTech
-
2022-02-25
Survey response — 12 months, dose 2MedDRA: Asthenia, Brain fog, COVID-19, Dysuria, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Omicron, headaches, unable to think straight, extreme weakness, very tired, no breathing difficulty, difficulty urinating. 01.12-19.2022, some lingering weakness, possibly thought processing too. · Healthcare visit (other): Difficulty urinatingMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-02-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-05-07
Dose 4 — Pfizer-BioNTech
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-14
- 2022-05-21
- 2022-05-28
- 2022-06-05
-
2022-06-19
Survey response — day 42, dose 4MedDRA: Nasal congestion, Pre-existing disease, Respiratory tract congestion, Self-medication — Feeling: GoodFree text: Mild nasal congestion, normally I would assign it to spring/summer allergies with a corresponding very mild upper chest congestion. Treating with over the counter allergy med.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-08
- 2022-11-05
- 2023-05-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | No |
| 4 | 2022-05-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): A bit out of sorts, no pain. Safe!
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Lack of motivation.
Release 11 — 12 months, dose 2
Symptoms: Omicron, headaches, unable to think straight, extreme weakness, very tired, no breathing difficulty, difficulty urinating. 01.12-19.2022, some lingering weakness, possibly thought processing too.
Healthcare visit (other): Difficulty urinating
Release 12 — day 42, dose 4
Symptoms: Mild nasal congestion, normally I would assign it to spring/summer allergies with a corresponding very mild upper chest congestion. Treating with over the counter allergy med.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Dysuria | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysuria | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Apathy | ✓ | ✓ | ✓ |
| SRO | Malaise | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release